D. J. Farrell

641 total citations
14 papers, 512 citations indexed

About

D. J. Farrell is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, D. J. Farrell has authored 14 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Epidemiology and 3 papers in Pharmacology. Recurrent topics in D. J. Farrell's work include Antimicrobial Resistance in Staphylococcus (4 papers), Pneumonia and Respiratory Infections (3 papers) and Antibiotic Resistance in Bacteria (3 papers). D. J. Farrell is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (4 papers), Pneumonia and Respiratory Infections (3 papers) and Antibiotic Resistance in Bacteria (3 papers). D. J. Farrell collaborates with scholars based in United States, Netherlands and Ireland. D. J. Farrell's co-authors include Ian Morrissey, M J Robbins, D. Felmingham, Hélio S. Sader, Ronald N. Jones, Robert K. Flamm, Rodrigo E. Mendes, Paul R. Rhomberg, Nicole E. Scangarella-Oman and Alex van Belkum and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

D. J. Farrell

13 papers receiving 471 citations

Peers

D. J. Farrell
Kelley A. Gordon United States
Ronald N. Master United States
S. Nys Netherlands
L. Gualco Italy
M. Dan Israel
D. Hoban Canada
Kelley A. Gordon United States
D. J. Farrell
Citations per year, relative to D. J. Farrell D. J. Farrell (= 1×) peers Kelley A. Gordon

Countries citing papers authored by D. J. Farrell

Since Specialization
Citations

This map shows the geographic impact of D. J. Farrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. J. Farrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. J. Farrell more than expected).

Fields of papers citing papers by D. J. Farrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. J. Farrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. J. Farrell. The network helps show where D. J. Farrell may publish in the future.

Co-authorship network of co-authors of D. J. Farrell

This figure shows the co-authorship network connecting the top 25 collaborators of D. J. Farrell. A scholar is included among the top collaborators of D. J. Farrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. J. Farrell. D. J. Farrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kealey, Carmel, et al.. (2018). Comparative activity of silver-based antimicrobial composites for urinary catheters. International Journal of Antimicrobial Agents. 52(2). 166–171. 14 indexed citations
2.
Antonation, Kym, Selina Patel, Daniel C. Alexander, et al.. (2017). Interim laboratory testing guidance for the detection of non-tuberculous Mycobacterium (NTM) infections in post-operative patients exposed to heater-cooler units. Canada Communicable Disease Report. 43(1). 25–28. 3 indexed citations
3.
Farrell, D. J., Hélio S. Sader, Paul R. Rhomberg, Nicole E. Scangarella-Oman, & Robert K. Flamm. (2017). In Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae. Antimicrobial Agents and Chemotherapy. 61(3). 52 indexed citations
4.
Flamm, Robert K., D. J. Farrell, Hélio S. Sader, & Ronald N. Jones. (2014). Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012). Journal of Antimicrobial Chemotherapy. 69(6). 1589–1598. 63 indexed citations
5.
Jones, Ronald N., D. J. Farrell, Rodrigo E. Mendes, & Hélio S. Sader. (2011). Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study. Journal of Antimicrobial Chemotherapy. 66(Supplement 3). iii69–iii80. 57 indexed citations
6.
Simjee, Shabbir, Štefan Schwarz, Robert E. Badal, et al.. (2011). VET05-R : Generation, presentation, and application of antimicrobial susceptibility test data for bacteria of animal origin : A Report. 17 indexed citations
7.
Farrell, D. J., et al.. (2010). Activity of Ceftaroline Against Recent (2009) and Multidrug-resistant Streptococcus pneumoniae Isolates from Europe and the United States. 3 indexed citations
8.
Farrell, D. J., Douglas J. Biedenbach, John P. Mueller, John P. Quinn, & Ronald N. Jones. (2010). IN VITRO ACTIVITY OF MC-1: A NEW GRAM-NEGATIVE ANTIMICROBIAL AGENT. 1 indexed citations
9.
10.
11.
Farrell, D. J., et al.. (2007). P1820 High prevalence of inducible clindamycin resistance among community-associated methicillin resistant Staphylococcus aureus in Europe. International Journal of Antimicrobial Agents. 29. S520–S520. 3 indexed citations
12.
Farrell, D. J., et al.. (2003). A UK Multicentre Study of the Antimicrobial Susceptibility of Bacterial Pathogens Causing Urinary Tract Infection. Journal of Infection. 46(2). 94–100. 250 indexed citations
13.
Farrell, D. J., et al.. (1996). Polydactyly in the pre-adolescent foot: An unusual case presentation with impending pathologic fracture. The Journal of Foot & Ankle Surgery. 35(1). 54–58. 3 indexed citations
14.
Holmes, M. & D. J. Farrell. (1993). ORCHARD MICROCLIMATE AS MODIFIED BY WINDBREAKS: A PRELIMINARY INVESTIGATION. 16. 59–64. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026